首页 | 本学科首页   官方微博 | 高级检索  
     

新生儿感染性黄疸患者C反应蛋白水平的变化及临床意义
引用本文:佘志婉,薛立军,童和平,张新玲. 新生儿感染性黄疸患者C反应蛋白水平的变化及临床意义[J]. 矿产勘查, 2011, 0(11): 53-54,59
作者姓名:佘志婉  薛立军  童和平  张新玲
作者单位:深圳市宝安区松岗人民医院儿科,广东深圳518105
摘    要:目的探讨血清C反应蛋白(CRP)在新生儿感染性黄疸疾病中的变化及临床意义。方法测定观察组(28例感染性黄疸新生儿)及对照组(50例生理性黄疸新生儿)治疗前后的总胆红素(TBIL)、间接胆红素(IBIL)、WBC、CRP指标,并对2组所测结果进行分析。结果观察组治疗前TBIL、IBIL、WBC、CRP指标均高于对照组,差异有统计学意义(P〈0.01);观察组治疗前后比较,差异亦有统计学意义(P〈0.01);排除胆红素的影响,血清CRP与WBC呈正相关(偏相关系数为0.8207,P〈0.01)。结论CRP可作为早期诊断新生儿感染性黄疸的指标之一,动态观察其水平变化有助于判定病情的演变及治疗效果。

关 键 词:新生儿黄疸  感染  C反应蛋白

Changes in C-reactive Protein in Neonates with Infectious Jaundice and Their Clinical Significance
SHE Zhi-wan. Changes in C-reactive Protein in Neonates with Infectious Jaundice and Their Clinical Significance[J]. Mineral Exploration, 2011, 0(11): 53-54,59
Authors:SHE Zhi-wan
Affiliation:Songgang People's Hospital of Shenzhen Bao 'an District, Shenzhen 518105 ,China)
Abstract:Objective To investigate the changes in serum C-reactive protein (CRP) in neonates with infectious jaundice and their clinical significance. Methods Total bilirubin(TBIL), indirect bilirubin (IBIL) ,white blood cell count (WBC) and CRP were determinated in 28 neonates with infectious jaundice (observation group) and 50 neonates with physiological jaundice (control group) before and after treatment. Results were compared between the two groups. Results Before treatment,the levels of TBIL, IBIL, WBC and CRP in observation group were significantly higher than those in control group (P〈0.01). There were statistically significant differences in these indexes before and after treatment (P〈0.01) ;Serum CRP was positively correlated with WBC by excluding the effects of bilirubin (partial correlation coefficient= 0. 820 7, P(0.01). Conclusion The CRP can be used as an indicator of infectious jaundice in neonates,and dynamic observation of CRP levels will help determine the disease evolution and therapeutic efficacy.
Keywords:neonatal jaundice  infection  C-reactive protein
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号